Activision Blizzard, Inc stock price, ATVI

Activision Blizzard, Inc stock chart:



Activision Blizzard, Inc close price: 49.87

Stock price forecast:

DOWN TO -5.84%
Target: 46.96

Total forecasts: 81
Reached: 16 (19.75%)

Total Win: 11.90 (30.01%)

DaysForecastsReached%Reached points%InvestedUnreached%Total%
90831720.48%13.100.40%3,144.14-147.28-4.68%-134.18-3.51%
302300.00%0.000.00%1,130.43-16.58-1.47%-16.58-1.47%
141500.00%0.000.00%736.67-11.38-1.54%-11.38-1.54%
7800.00%0.000.00%393.85-5.11-1.30%-5.11-1.30%

Showing 1-10 of 539 items.
Date of ForecastStock PriceTarget PriceForecast Reached Date
2017-04-2349.8746.960000-00-00
2017-04-2249.8746.770000-00-00
2017-04-2149.9546.640000-00-00
2017-04-2049.3546.250000-00-00
2017-04-1949.1746.020000-00-00
2017-04-1848.845.630000-00-00
2017-04-1748.4245.20000-00-00
2017-04-1648.4245.060000-00-00
2017-04-1548.4244.910000-00-00
2017-04-1448.4244.760000-00-00

Activision Blizzard, Inc latest news:


  • 02/14/2017 14:47:05

    George Soros picks up Goldman Sachs, dumps Nvidia

    George Soros's hedge fund Soros Fund Management made a lot of changes to his portfolio in the fourth quarter, dumping positions in many companies and initiating positions in Goldman Sachs Group Inc. and Pandora Media Inc. . Soros decreased positions in Abbott Labs , Amazon.com Inc. , eBay Inc. , Netflix Inc. , and VMware Inc. . Soros also dumped positions in Activision Blizzard Inc. , Amgen Inc. , Barrick Gold Corp. , Coca-Cola Co. and Nvidia Corp. .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 02/09/2017 14:29:37

    Activision Blizzard shares jump on stock buyback, dividend hike

    Shares of Activision Blizzard Inc. (ATVI) soared in Thursday's extended session after the videogame company announced a $1 billion stock buyback plan and raised its quarterly dividend to 30 cents from 26 cents. However, it posted disappointing quarterly results. Activision reported its fourth-quarter earnings rose to $254 million, or 33 cents a share, versus $159 million, or 22 cents a share, a year earlier.

  • More trends:

    Actua CorporationACTA | Acura Pharmaceuticals, Inc.ACUR | Acxiom CorporationACXM | Adamas Pharmaceuticals, Inc.ADMS | Adamis Pharmaceuticals CorporationADMP | Adaptimmune Therapeutics plcADAP | Addus HomeCare CorporationADUS | ADDvantage Technologies Group, Inc.AEY | Adept Technology, Inc.ADEP | ADMA Biologics IncADMA |